Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety-Reference-Cited by-同舟云学术

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety

Published:2009-08-31 Issue:1 Volume:51 Page:165-173
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vitale Alessandro,Volk Michael L.,Pastorelli Davide,Lonardi Sara,Farinati Fabio,Burra Patrizia,Angeli Paolo,Cillo Umberto

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23260/fullpdf

Reference27 articles.

1. The OPTN waiting list, 1988-2000;Harper;Clin Transplant,2001

2. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation;Llovet;HEPATOLOGY,1999

3. The model for end-stage liver disease comes of age;Freeman;Clin Liver Dis,2007

4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

5. Liver transplantation for hepatocellular carcinoma. Analysis of survival according to the intention-to-treat principle, and drop-out from the waiting list;Yao;Liver Transpl,2002

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults;Gut;2024-04-16

2. Immune checkpoint inhibitors in liver transplantation: Current practice, challenges, and opportunities;Liver Transplantation;2024-02-13

3. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy;World Journal of Gastroenterology;2023-03-21

4. The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile;International Journal of Environmental Research and Public Health;2022-12-06

5. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation;Transplant International;2022-11-09